These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36246067)

  • 21. Clostridial disease associated with neurologic signs: tetanus, botulism, and enterotoxemia.
    Rings DM
    Vet Clin North Am Food Anim Pract; 2004 Jul; 20(2):379-91, vii-viii. PubMed ID: 15203231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination of turkeys with Clostridium septicum bacterin-toxoid: evaluation of protection against clostridial dermatitis.
    Thachil AJ; McComb B; Kromm M; Nagaraja KV
    Avian Dis; 2013 Jun; 57(2):214-9. PubMed ID: 24689176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and Purification of Subunit Vaccines for Prevention of Clostridium difficile Infection.
    Karczewski J; Bodmer JL; Cook JC; Xoconostle RF; Nahas DD; Joyce JG; Heinrichs JH; Secore S
    Methods Mol Biol; 2016; 1403():385-96. PubMed ID: 27076142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
    Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
    Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic characteristics of toxigenic Clostridia and toxin gene evolution.
    Popoff MR; Bouvet P
    Toxicon; 2013 Dec; 75():63-89. PubMed ID: 23707611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile disease.
    Ghose C; Verhagen JM; Chen X; Yu J; Huang Y; Chenesseau O; Kelly CP; Ho DD
    Infect Immun; 2013 Jun; 81(6):2190-6. PubMed ID: 23545305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of toxin production in the pathogenic clostridia.
    Carter GP; Cheung JK; Larcombe S; Lyras D
    Mol Microbiol; 2014 Jan; 91(2):221-31. PubMed ID: 24563915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Toxin-infections and toxin-related diseases due to Clostridia other than
    Duss FR; Voide C
    Rev Med Suisse; 2018 Oct; 14(622):1795-1798. PubMed ID: 30307139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An international survey of clostridial sera and vaccines.
    Davidson I
    Dev Biol Stand; 1976; 32():3-14. PubMed ID: 187508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress toward development of an inhalation vaccine against botulinum toxin.
    Park JB; Simpson LL
    Expert Rev Vaccines; 2004 Aug; 3(4):477-87. PubMed ID: 15270652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults.
    Sheldon E; Kitchin N; Peng Y; Eiden J; Gruber W; Johnson E; Jansen KU; Pride MW; Pedneault L
    Vaccine; 2016 Apr; 34(18):2082-91. PubMed ID: 26993331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection.
    Wang H; Sun X; Zhang Y; Li S; Chen K; Shi L; Nie W; Kumar R; Tzipori S; Wang J; Savidge T; Feng H
    Infect Immun; 2012 Aug; 80(8):2678-88. PubMed ID: 22615245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxigenic clostridia.
    Hatheway CL
    Clin Microbiol Rev; 1990 Jan; 3(1):66-98. PubMed ID: 2404569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenic anaerobic bacteria and the environment.
    Haagsma J
    Rev Sci Tech; 1991 Sep; 10(3):749-64. PubMed ID: 1782427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulism and vaccines for its prevention.
    Smith LA
    Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enterotoxic Clostridia:
    Mileto S; Das A; Lyras D
    Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31124432
    [No Abstract]   [Full Text] [Related]  

  • 37. Large Clostridial Toxins: Mechanisms and Roles in Disease.
    Orrell KE; Melnyk RA
    Microbiol Mol Biol Rev; 2021 Aug; 85(3):e0006421. PubMed ID: 34076506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridial Genetics: Genetic Manipulation of the Pathogenic Clostridia.
    Kuehne SA; Rood JI; Lyras D
    Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31172914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intradermal immunization with botulinum neurotoxin serotype E DNA vaccine induces humoral and cellular immunity and protects against lethal toxin challenge.
    Kim NY; Ahn HB; Yu CH; Song DH; Hur GH; Shin YK; Shin S
    Hum Vaccin Immunother; 2019; 15(2):412-419. PubMed ID: 30235058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins.
    Schirmer J; Aktories K
    Biochim Biophys Acta; 2004 Jul; 1673(1-2):66-74. PubMed ID: 15238250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.